DermTech Reports Fourth Quarter and Full Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall Street dips on hot inflation data ahead of Nvidia earnings
- Oil rises as investors weigh Hormuz talks
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Citi sees an opportunity in Oracle after ’one of the most extreme’ stock drawdowns
- Boston Scientific discloses cybersecurity incident causing global disruption
- Wall Street ends higher as tech rebounds before Nvidia results
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
DermTech (DMTK) Misses Q4 EPS by 15c
March 1, 2022 4:03 PM ESTDermTech (NASDAQ: DMTK) reported Q4 EPS of ($0.88), $0.15 worse than the analyst estimate of ($0.73). Revenue for the quarter came in at $3.2 million versus the consensus estimate of $3.4 million.
For earnings history and earnings-related data on DermTech (DMTK) click here.
... More